Alcohol-Related Liver Disease (ALD) SIGUnhealthy alcohol use, alcohol-associated liver disease (ALD), and liver transplants for ALD are rising worldwide; the coronavirus disease 2019 pandemic has only exacerbated the trends. ALD already accounts for over 40% of all liver-related deaths globally, and models project ALD-related mortality to double by 2040. The optimal care of liver transplant candidates/recipients with ALD requires an integrated community of medical, surgical, and substance use providers. However, strategies for implementing best practices often vary depending on local and national health policies. The diverse international membership of ILTS is therefore well-positioned to lead efforts toward addressing this significant public health issue. The mission of the new Alcohol and Substance Use Topics in Liver Transplantation SIG will be to advance the care of liver transplant candidates/recipients with alcohol use disorder (AUD) and ALD through education and research. SIG’s Aims:
|